Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s drug controller will keep falsified meds out of EU, but GMP standard may be lower

This article was originally published in Scrip

Executive Summary

India has confirmed that the Central Drugs Standards Control Organization (CDSCO)/Drugs Controller General of India (DCGI) will be the agency designated to certify active pharmaceutical ingredient (API) exports to the EU. However, GMP equivalence issues have yet to be resolved. Indian industry has suggested that the WHO GMP standard for those ingredients, which differs from the EU GMP standard, would be appropriate. It is not clear that the EU accepts this view.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts